CARDIAI
CardiAI™ is a medical device research and development organization in Western Canada. At CardiAI™, we are developing platform-based medical diagnostics devices and software that will transform healthcare worldwide. These health care technologies will provide a sense of assured future and stability impact by improving patient care around the world. CardiAI™ prioritizes patient-centered care by understanding and emphasizing patient needs to their health care and information providers. Our research and development team consists of; cardiologists, biochemists, engineers, molecular biologists, project manages, clinical trial specialists and astute business leaders who have a combined total of 150 years of dedicated experience and expertise.
Calgary, Alberta (AB), Canada
Healthcare
People
About
About
CardiAI is a data-driven company that harnesses technical innovation to create positive outcomes for patients. CardiAI is creating a handheld medical device that can rapidly diagnose, manage and monitor infectious diseases and chronic health conditions. We have a team of dedicated scientists, clinical researchers and hardware developers who work together to develop rapid diagnostic tools.
CardiAi has created a point-of-care device to detect Covid-19 and biomarkers for other chronic diseases.
Patients can use the device to test themselves and send the results to their physician. The physician then has all the information they need to deliver highly personalized care.
The device is part of a technology platform that uses data and analytics to enhance patient care. Advanced analytics powered by machine learning can provide insights for patients, healthcare providers and insurance companies and drives the health care system towards integration.
CardiAI’s machine learning and data processing allows for fast and efficient prediction models by leveraging historical and real time data.
With CardiAI’s data collection and analytics platform, healthcare service providers can make better decisions for a patient’s diagnosis and treatment.
CardiAi has created a point-of-care device to detect Covid-19 and biomarkers for other chronic diseases.
Patients can use the device to test themselves and send the results to their physician. The physician then has all the information they need to deliver highly personalized care.
The device is part of a technology platform that uses data and analytics to enhance patient care. Advanced analytics powered by machine learning can provide insights for patients, healthcare providers and insurance companies and drives the health care system towards integration.
CardiAI’s machine learning and data processing allows for fast and efficient prediction models by leveraging historical and real time data.
With CardiAI’s data collection and analytics platform, healthcare service providers can make better decisions for a patient’s diagnosis and treatment.
Add Attachment
Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link